Thomas Group - Grants
- Australian Arthritis and Autoimmune Biobank Collaborative (A3BC)
(2019–2022) University of Sydney - Development of antigen-specific immunotherapy for Wegener's granulomatosis
(2018–2023) Research Donation Generic - Towards prevention of Rheumatoid Arthritis: Harnessing the power of probiotic species
(2018–2023) Research Donation Generic - ITN Study: Preserving Beta-Cell Function with Tocilizumab in New-onset Type 1 Diabetes (NIH Grant Administered by Benaroya Research Institute at Virginia Mason)
(2018–2020) Immune Tolerance Network - NIAID/NIH under grant number 5UM1AI109565 - administered by Benaroya Research Institute at Virginia Mason - Oral liposomes for antigen-specific immunotherapy of type 1 diabetes
(2018–2019) Diabetes Australia Research Trust - NHMRC Research Fellowship: Understanding the basis of autoimmunity in rheumatoid arthritis and type 1 diabetes to underpin the implementation of antigen-specific therapies
(2015–2020) NHMRC Research Fellowship - Professorial Chair in Rheumatology
(2013–2020) Arthritis Foundation of Queensland